|
Volumn 22, Issue 3, 2009, Pages 329-334
|
Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates
|
Author keywords
Bioavailability; Ciprofloxacin; Dissolution rates and in vivo in vitro correlation
|
Indexed keywords
CIPROFLOXACIN;
ANTIINFECTIVE AGENT;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISSOLUTION;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG METABOLISM;
GLOMERULUS FILTRATION;
HUMAN;
HUMAN EXPERIMENT;
KIDNEY TUBULE;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MICROBIOLOGICAL EXAMINATION;
NORMAL HUMAN;
SPECTROPHOTOMETRY;
TABLET FORMULATION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
BIOAVAILABILITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
PHARMACOKINETICS;
RANDOMIZED CONTROLLED TRIAL;
SOLUBILITY;
TABLET;
TIME;
ADULT;
ANTI-INFECTIVE AGENTS;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CIPROFLOXACIN;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MALE;
MICROBIAL SENSITIVITY TESTS;
SOLUBILITY;
TABLETS;
THERAPEUTIC EQUIVALENCY;
TIME FACTORS;
|
EID: 68549107937
PISSN: 1011601X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (4)
|